ZLAB
Zai Lab Ltd
NASDAQ: ZLAB · HEALTHCARE · BIOTECHNOLOGY
$21.64
+4.29% today
Updated 2026-04-30
Market cap
$2.33B
P/E ratio
—
P/S ratio
5.07x
EPS (TTM)
$-1.60
Dividend yield
—
52W range
$16 – $44
Volume
0.8M
Zai Lab Ltd (ZLAB) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-38.20%
Operating margin
-54.40%
ROE
-22.60%
ROA
-12.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-18.02M | — | — | — |
| 2016 | $0.00 | $-37.51M | — | — | — |
| 2017 | $0.00 | $-50.38M | — | — | — |
| 2018 | $129452.00 | $-139.07M | 66.33% | -109,514.01% | -107,433.56% |
| 2019 | $12.98M | $-183.37M | 71.13% | -1,564.88% | -1,412.16% |
| 2020 | $48.96M | $-268.90M | -389.09% | -616.45% | -549.26% |
| 2021 | $144.31M | $-704.47M | 63.80% | -485.10% | -488.16% |
| 2022 | $215.04M | $-443.29M | 65.58% | -188.04% | -206.14% |
| 2023 | $266.72M | $-334.62M | 64.08% | -137.44% | -125.46% |
| 2024 | $398.99M | $-257.10M | 62.94% | -70.71% | -64.44% |
| 2025 | $460.16M | $-175.54M | 58.60% | -49.86% | -38.15% |